CIDEC is most closely associated with fat storage in human adipose tissue among CIDE family isoforms in severely obese subjects: a cross-sectional study
- PMID: 40607154
- PMCID: PMC12209148
- DOI: 10.1007/s13340-025-00806-0
CIDEC is most closely associated with fat storage in human adipose tissue among CIDE family isoforms in severely obese subjects: a cross-sectional study
Abstract
The cell death-inducing DFF45-like effector (CIDE) family comprises CIDEA, CIDEB, and CIDEC (fat-specific protein of 27 kDa), all of which are lipid droplet-associated proteins and contribute to fat storage and energy homeostasis. However, the relative impacts of these isoforms on fat storage in adipose tissue and obesity in humans have been unclear. We here examined the expression of CIDE family genes in visceral adipose tissue (VAT) of obese individuals who underwent laparoscopic sleeve gastrectomy and explored its relation to adiposity-related parameters. RNA-sequencing analysis revealed that CIDEA and CIDEC were highly expressed in VAT, whereas CIDEB was expressed at a substantially lower level. CIDEA and CIDEC expression levels were positively correlated with body fat mass and subcutaneous adipose tissue (SAT) area, whereas CIDEB expression was negatively correlated with these markers. In addition, CIDEC and CIDEB expression levels showed positive and negative correlations, respectively, with BMI. Multivariable regression analysis showed that only CIDEC expression was significantly associated with body fat mass. Stratification of the subjects according to tertiles of CIDEC expression revealed that BMI, body fat mass, and SAT area were significantly greater in the highest CIDEC expression group than in the other two groups. Our findings thus suggest that, among CIDE isoforms, CIDEC is the most closely associated with fat storage in human adipose tissue.
Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00806-0.
Keywords: Adipose tissue; CIDEC; Fat mass; Obesity.
© The Japan Diabetes Society 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestAll the affiliations or financial involvement with any organization or financial conflict with the subject matter discussed in the manuscript are completely disclosed in this section. Yushi Hirota received lecture fees from Eli Lilly Japan K.K., Sanofi Aventis, Abbott Japan, Terumo Co., Novo Nordisk Pharma Ltd., and Sumitomo Pharma Co. Ltd. Yushi Hirota received a research funding from Sumitomo Pharma Co., Ltd., Medtronic Japan Co., Ltd., and Kyowa Kirin Co., Ltd. Yushi Hirota received a donation from Abbott Japan. Kazuhiko Sakaguchi received lecture fees from Sumitomo Pharma Co., Ltd., Novo Nordisk Pharma Ltd., Novartis Pharma K.K., Sanofi K.K., Eli Lilly Japan K.K., and MSD K.K. Kazuhiko Sakaguchi received a research grant from Sumitomo Pharma Co., Ltd. Wataru Ogawa received lecture fees from Sumitomo Pharma Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Abbott Japan, and Novo Nordisk Pharma Ltd. Wataru Ogawa received a research grant from Noster, Nippon Boehringer Ingelheim Co., Ltd., Boehringer Ingelheim Pharma GmbH and Co. KG, Co., Ltd., Eli Lilly Japan K.K., Sumitomo Pharma Co., Ltd., and Novo Nordisk Pharma Ltd. Wataru Ogawa received a donation from Sumitomo Pharma Co., Ltd. Yasuyuki Iwahashi, Seiji Nishikage, Yusei Hosokawa, Tomoko Yamada, Yasushi Nakagawa, Yuki Nishimoto, Shinsuke Nakajima, Seiichi Kitahama, Yasuyoshi Yamamoto, Tomoichiro Mukai, and Yoshikazu Tamori declare that they have no conflict of interest.
Similar articles
-
Cell death-inducing DFF45-like effector C intervenes the progression of non-small cell lung cancer via modulating lipid metabolism.Int J Surg. 2025 Jun 24. doi: 10.1097/JS9.0000000000002796. Online ahead of print. Int J Surg. 2025. PMID: 40552859
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article.
References
-
- Chen FJ, Yin Y, Chua BT, Li P. CIDE family proteins control lipid homeostasis and the development of metabolic diseases. Traffic. 2020;21:94–105. - PubMed
-
- Zhou Z, Toh SY, Chen Z, Guo K, Ng CP, Ponniah S, et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet. 2003;35:49–56. - PubMed
-
- Li JZ, Ye J, Xue B, Qi J, Zhang J, Zhou Z, et al. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes. 2007;56:2523–32. - PubMed
LinkOut - more resources
Research Materials